Effect of anti-angiogenic drugs along with chemotherapy in breast cancer treatment: review article

Nasiri, Najibeh and Avan, Amir and Hassanian, Seyed Mahdi and Khazaei, Majid (2019) Effect of anti-angiogenic drugs along with chemotherapy in breast cancer treatment: review article. The Iranian Journal of Obstetrics, Gynecology and Infertility, 22 (5). pp. 78-89.

[img] Text
IJOGI_Volume 22_Issue 5_Pages 78-89.pdf

Download (580kB)
Official URL: http://ijogi.mums.ac.ir/article_13586.html

Abstract

Introduction: Cancer is one of the most common causes of death in the world and breast cancer is known as the second leading cause of death in women worldwide. Breast cancer is a heterogeneous tumor; various studies have shown that angiogenesis plays an important role in progression and development of cancer. Clinical studies have been performed on the relationship between anti-angiogenic drugs along with chemotherapy in improvement of breast cancer treatment. This review article was performed with aim to evaluate the effect of anti-angiogenic drugs along with chemotherapy in breast cancer treatment. Methods: In this review study, the related articles were searched in databases of Scopus, PubMed, ISI and Google scholar by the key words including “Breast cancer”, “Anti-angiogenic drug”, ” Chemotherapy” and “Angiogenesis” in Mesh between 2000-2018. No time limitation was considered in selection of the articles. Selection of the articles was based on use of anti-angiogenic drugs along with chemotherapy or as part of chemotherapy drugs in breast cancer treatment. At the end of study, data were analyzed qualitatively. Results: According to the studies’ results, it was determined that use of anti-angiogenic drugs in improving breast cancer treatment could be more investigated. VEGF and VEGFR inhibitors have shown different clinical effects that could be due to differences in dosage, method of consumption or drug interactions. Conclusion: Although anti-angiogenic drugs have positive role in improving breast cancer treatment, since different results in doses and method of consumption of these drugs were observed in clinical trials, performing more studies in this regard is required. In general, it seems that these drugs in combination with standard chemotherapy agents could be a good candidate for treatment and increasing survival rate in breast cancer patients.

Item Type: Article
Uncontrolled Keywords: Anti angiogenic drug,Breast Cancer,VEGF
Subjects: WP Gynecology
WQ Obstetrics
Divisions: Journals > Iranian J Obstetrics, Gynecology and Infertility
Depositing User: ijogi ijogi
Date Deposited: 08 Aug 2019 06:52
Last Modified: 08 Aug 2019 06:52
URI: http://eprints.mums.ac.ir/id/eprint/11897

Actions (login required)

View Item View Item